These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11801715)

  • 1. Sestamibi scanning of breast cancer.
    Shaffer P
    J Nucl Med; 2002 Jan; 43(1):125-6. PubMed ID: 11801715
    [No Abstract]   [Full Text] [Related]  

  • 2. [To the Editor: Regarding the role of MIBI-scintigraphy in the early diagnosis of breast cancer].
    Péley G
    Magy Seb; 2001 Aug; 54(4):259-61. PubMed ID: 11550498
    [No Abstract]   [Full Text] [Related]  

  • 3. Tc-99m sestamibi exam finds niche in breast Dx.
    Chen EM; Khalkhali I; Cutrone JA; Diggles LE; Mishkin F
    Diagn Imaging (San Franc); 1997 Aug; 19(8):61-5. PubMed ID: 10169379
    [No Abstract]   [Full Text] [Related]  

  • 4. Decision analysis: MIBI imaging of nonpalpable breast abnormalities.
    Hillner BE
    J Nucl Med; 1997 Nov; 38(11):1772-8. PubMed ID: 9374352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
    Waxman AD
    J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353
    [No Abstract]   [Full Text] [Related]  

  • 6. Tc-99m sestamibi scintimammography: where is it now?
    Schillaci O; Scopinaro F
    Cancer Biother Radiopharm; 1999 Dec; 14(6):417-22. PubMed ID: 10850328
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.
    Khalkhali I; Villanueva-Meyer J; Edell SL; Connolly JL; Schnitt SJ; Baum JK; Houlihan MJ; Jenkins RM; Haber SB
    J Nucl Med; 2000 Dec; 41(12):1973-9. PubMed ID: 11138681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scintigraphy does no show small nodules of the breast].
    Rofo; 1997 Nov; 167(5):M40. PubMed ID: 9440886
    [No Abstract]   [Full Text] [Related]  

  • 9. What can we expect from MDR breast cancer imaging with sestamibi?
    Palmedo H
    J Nucl Med; 2002 Apr; 43(4):526-30. PubMed ID: 11937597
    [No Abstract]   [Full Text] [Related]  

  • 10. Occult breast cancer detection with technetium-99m-sestamibi: a case report.
    Park YH; Ferrante J; Robinson RE; Arvay K
    J Nucl Med Technol; 1999 Dec; 27(4):298-300. PubMed ID: 10646550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer.
    Derebek E
    Eur J Nucl Med; 1998 Apr; 25(4):448. PubMed ID: 9643975
    [No Abstract]   [Full Text] [Related]  

  • 12. Technologic advances in breast imaging. Current and future strategies, controversies, and opportunities.
    Hall FM
    Surg Oncol Clin N Am; 1997 Apr; 6(2):403-9. PubMed ID: 9115505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast.
    Ohta H; Yamamoto S; Ukikusa M; Awane H; Shintaku M; Irie K
    Clin Nucl Med; 1997 Aug; 22(8):553-4. PubMed ID: 9262903
    [No Abstract]   [Full Text] [Related]  

  • 14. The difficult breast.
    Ziewacz JT; Neumann DP; Weiner RE
    Surg Oncol Clin N Am; 1999 Jan; 8(1):17-33. PubMed ID: 9824360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Mirzaei S; Knoll P; Lipp RW; Köhn H
    J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Servais F; Blocklet DC; Seret AE; Lenaers A; Schoutens AC
    Radiology; 1997 Oct; 205(1):283; author reply 285-6. PubMed ID: 9315001
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Delpassand ES; Jackson EF
    Radiology; 1997 Oct; 205(1):283-4; author reply 285-6. PubMed ID: 9315002
    [No Abstract]   [Full Text] [Related]  

  • 19. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of occult breast carcinoma during evaluation of a skeletal tumor by Tc-99m MIBI scintigraphy.
    Hod N; Mindlin L; Horne T
    Isr Med Assoc J; 2003 Apr; 5(4):296-7. PubMed ID: 14509141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.